⌘K

Home/Filings/4/0001127602-23-023845

4//SEC Filing

SCHEIBLER LUKAS 4

Accession 0001127602-23-023845

CIK 0001492422other

View on SEC.gov Company Profile

Filed

Sep 6, 8:00 PM ET

Accepted

Sep 7, 4:08 PM ET

Size

4.4 KB

Accession

0001127602-23-023845

Insider Transaction Report

Form 4

Period: 2023-09-06

Apellis Pharmaceuticals, Inc.APLS

SCHEIBLER LUKAS

See Remarks

Transactions

Sale
Common Stock
2023-09-06$43.01/sh−1,756$75,526→ 68,299 total

Footnotes (1)

[F1]This includes 412 shares from 04/30/2023 ESPP purchase.

Documents

1 file

4
form4.xmlPrimary
PRIMARY DOCUMENT

Issuer

Apellis Pharmaceuticals, Inc.

CIK 0001492422

Entity typeother

Related Parties

1

filerCIK 0001651281

Filing Metadata

Form type: 4
Filed: Sep 6, 8:00 PM ET
Accepted: Sep 7, 4:08 PM ET
Size: 4.4 KB

View on SEC.gov